Mjt & Associates Financial Advisory Group, Inc. Astrazeneca PLC Transaction History
Mjt & Associates Financial Advisory Group, Inc.
- $104 Billion
- Q1 2025
A detailed history of Mjt & Associates Financial Advisory Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Mjt & Associates Financial Advisory Group, Inc. holds 161 shares of AZN stock, worth $11,606. This represents 0.01% of its overall portfolio holdings.
Number of Shares
161Holding current value
$11,606% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,392Shares Held
472MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.35 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.96 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.7 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.73 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.4 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...